BDC-4182: A Claudin 18.2-Targeting ISAC with Significantly Enhanced Immune Activity and Efficacy in Low Antigen Density Models
3:15 pm - Thursday 19th March 2026
- Integrating saRNA and siRNA payloads into antibody conjugates
- Managing immunogenicity and safety considerations
- Identifying the next wave of oligonucleotide drug conjugate candidates
